SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001213900-20-017821
Filing Date
2020-07-17
Accepted
2020-07-17 16:46:56
Documents
6

Document Format Files

Seq Description Document Type Size
1 REGISTRATION STATEMENT ea124228-s3_soligenix.htm S-3 220100
2 OPINION OF DUANE MORRIS LLP ea124228ex5-1_soligenix.htm EX-5.1 35415
3 CONSENT OF EISNERAMPER LLP ea124228ex23-1_soligenix.htm EX-23.1 4645
4 GRAPHIC img_001.jpg GRAPHIC 2307
5 GRAPHIC img_002.jpg GRAPHIC 4885
6 GRAPHIC ex5-1_001.jpg GRAPHIC 6783
  Complete submission text file 0001213900-20-017821.txt   281067
Mailing Address 29 EMMONS DRIVE SUITE B-10 PRINCETON NJ 08540
Business Address 29 EMMONS DRIVE SUITE B-10 PRINCETON NJ 08540 609-538-8200
SOLIGENIX, INC. (Filer) CIK: 0000812796 (see all company filings)

IRS No.: 411505029 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-239928 | Film No.: 201034172
SIC: 2834 Pharmaceutical Preparations